• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组活化凝血因子 VII 和凝血酶原复合物浓缩物在减少实验性华法林相关性脑出血血肿体积方面同样有效。

Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.

机构信息

Department of Neurology, Goethe-University, Schleusenweg 2-16, 60528 Frankfurt am Main, Germany.

出版信息

Stroke. 2012 Jan;43(1):246-9. doi: 10.1161/STROKEAHA.111.629360. Epub 2011 Oct 13.

DOI:10.1161/STROKEAHA.111.629360
PMID:21998055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3722613/
Abstract

BACKGROUND AND PURPOSE

Based on an experimental model of warfarin-associated intracerebral hemorrhage, we investigated whether the rapid reversal of anticoagulation using prothrombin complex concentrates (PCC) or recombinant activated coagulation factor VII (rFVIIa) reduces hematoma volume.

METHODS

Mice were orally pretreated with warfarin (2 mg/kg). Intracerebral hemorrhage was induced by collagenase injection into the right striatum. Forty-five minutes later, PCC (100 IE/kg), rFVIIa (1 mg/kg), or an equal volume of saline was administered intravenously. Hematoma volume after 24 hours was quantified using a photometric hemoglobin assay.

RESULTS

International normalized ratio was 4.3±0.4 in saline-treated mice, 0.9±0.1 in rFVIIa mice, and 1.4±0.2 in PCC mice. Intracerebral hemorrhage volume was 29.0±19.7 μL in the saline group (n=7), 8.6±4.3 μL in the rFVIIa group (n=6), and 6.1±1.8 μL in the PCC group (n=7; analysis of variance between-group differences P=0.004; post hoc rFVIIa versus saline P=0.021; PCC versus saline P=0.007). No significant difference was found between PCC- and rFVIIa-treated animals.

CONCLUSIONS

Our results suggest that PCC and rFVIIa are equally effective in restoring coagulation and preventing excessive hematoma growth in acute warfarin-associated intracerebral hemorrhage.

摘要

背景与目的

基于华法林相关性脑出血的实验模型,我们研究了使用凝血酶原复合物浓缩物(PCC)或重组活化凝血因子 VII(rFVIIa)快速逆转抗凝是否能减少血肿体积。

方法

小鼠经口给予华法林(2mg/kg)预处理。通过将胶原酶注入右侧纹状体诱导脑出血。45 分钟后,静脉内给予 PCC(100IE/kg)、rFVIIa(1mg/kg)或等量生理盐水。使用比色法血红蛋白测定法在 24 小时后定量血肿体积。

结果

在生理盐水处理的小鼠中,国际标准化比值为 4.3±0.4,rFVIIa 小鼠为 0.9±0.1,PCC 小鼠为 1.4±0.2。在生理盐水组(n=7)、rFVIIa 组(n=6)和 PCC 组(n=7)中,脑出血体积分别为 29.0±19.7μL、8.6±4.3μL 和 6.1±1.8μL。组间差异的方差分析 P=0.004;rFVIIa 与生理盐水相比 P=0.021;PCC 与生理盐水相比 P=0.007。PCC 和 rFVIIa 治疗的动物之间未发现显著差异。

结论

我们的结果表明,PCC 和 rFVIIa 在恢复凝血和预防急性华法林相关性脑出血中过量血肿增长方面同样有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de9/3722613/390ed64c5afc/nihms482822f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de9/3722613/42db07dceb36/nihms482822f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de9/3722613/6dbfcba85b1f/nihms482822f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de9/3722613/390ed64c5afc/nihms482822f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de9/3722613/42db07dceb36/nihms482822f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de9/3722613/6dbfcba85b1f/nihms482822f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de9/3722613/390ed64c5afc/nihms482822f3.jpg

相似文献

1
Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.重组活化凝血因子 VII 和凝血酶原复合物浓缩物在减少实验性华法林相关性脑出血血肿体积方面同样有效。
Stroke. 2012 Jan;43(1):246-9. doi: 10.1161/STROKEAHA.111.629360. Epub 2011 Oct 13.
2
Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage.实验性华法林相关性脑出血中止血治疗的疗效比较。
Stroke. 2011 Jan;42(1):191-5. doi: 10.1161/STROKEAHA.110.593541. Epub 2010 Dec 2.
3
Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage.在华法林相关脑出血小鼠模型中,快速逆转抗凝可减少出血量。
J Cereb Blood Flow Metab. 2009 May;29(5):1015-21. doi: 10.1038/jcbfm.2009.27. Epub 2009 Mar 25.
4
Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.双能 CT 成像在抗凝相关脑出血中对比剂外渗的应用。
Stroke. 2013 Oct;44(10):2883-90. doi: 10.1161/STROKEAHA.113.001224. Epub 2013 Aug 6.
5
Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.在华法林血栓预防期间,重组活化因子VII用于逆转中枢神经系统出血时的国际标准化比值:临床和生化方面
Blood Coagul Fibrinolysis. 2003 Jul;14(5):469-77. doi: 10.1097/00001721-200307000-00007.
6
Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.达比加群或华法林抗凝期间外伤性脑损伤的转化见解。
J Cereb Blood Flow Metab. 2014 May;34(5):870-5. doi: 10.1038/jcbfm.2014.31. Epub 2014 Feb 19.
7
Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage.抗凝血相关脑出血患者应用凝血酶原复合物浓缩物对血肿扩大和临床转归的影响。
Cerebrovasc Dis. 2011;31(2):170-6. doi: 10.1159/000321766. Epub 2010 Dec 3.
8
Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.争分夺秒:克服抗凝相关脑出血管理中的挑战。
J Neurosurg. 2014 Aug;121 Suppl:1-20. doi: 10.3171/2014.8.paradigm.
9
Experimental model of warfarin-associated intracerebral hemorrhage.华法林相关脑出血的实验模型
Stroke. 2008 Dec;39(12):3397-404. doi: 10.1161/STROKEAHA.108.517482. Epub 2008 Sep 4.
10
Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban.与利伐沙班相关的实验性脑出血的止血治疗。
Stroke. 2013 Mar;44(3):771-8. doi: 10.1161/STROKEAHA.112.675231. Epub 2013 Jan 22.

引用本文的文献

1
Glibenclamide pretreatment attenuates early hematoma expansion of warfarin-associated intracerebral hemorrhage in rats by alleviating perihematomal blood-brain barrier dysfunction.格列本脲预处理通过减轻血肿周围血脑屏障功能障碍,减轻大鼠华法林相关性脑出血的早期血肿扩大。
Chin Neurosurg J. 2023 Dec 7;9(1):35. doi: 10.1186/s41016-023-00351-2.
2
Modified Protocol to Enable the Study of Hemorrhage and Hematoma in a Traumatic Brain Injury Mouse Model.改良方案以实现对创伤性脑损伤小鼠模型中出血和血肿的研究。
Front Neurol. 2021 Sep 28;12:717513. doi: 10.3389/fneur.2021.717513. eCollection 2021.
3
Relationship Between Hematoma Expansion Induced by Hypertension and Hyperglycemia and Blood-brain Barrier Disruption in Mice and Its Possible Mechanism: Role of Aquaporin-4 and Connexin43.高血压和高血糖诱导的血肿扩大与小鼠血脑屏障破坏之间的关系及其可能机制:水通道蛋白-4和连接蛋白43的作用
Neurosci Bull. 2020 Nov;36(11):1369-1380. doi: 10.1007/s12264-020-00540-4. Epub 2020 Jul 5.
4
Secondary Bleeding During Acute Experimental Intracerebral Hemorrhage.急性实验性脑出血中的继发性出血。
Stroke. 2019 May;50(5):1210-1215. doi: 10.1161/STROKEAHA.118.021732.
5
[Direct oral anticoagulants and acute stroke : Insights into translational research studies].[直接口服抗凝剂与急性中风:对转化研究的见解]
Nervenarzt. 2017 Jun;88(6):642-651. doi: 10.1007/s00115-017-0282-6.
6
Treatment with FTY720 has no beneficial effects on short-term outcome in an experimental model of intracerebral hemorrhage.在脑出血实验模型中,使用FTY720治疗对短期预后没有有益影响。
Exp Transl Stroke Med. 2016 Feb 18;8:1. doi: 10.1186/s13231-016-0016-z. eCollection 2016.
7
The Pathophysiology of Intracerebral Hemorrhage Formation and Expansion.脑出血形成与扩大的病理生理学
Transl Stroke Res. 2015 Aug;6(4):257-63. doi: 10.1007/s12975-015-0410-1. Epub 2015 Jun 16.
8
Warfarin pretreatment reduces cell death and MMP-9 activity in experimental intracerebral hemorrhage.华法林预处理可减少实验性脑出血中的细胞死亡和基质金属蛋白酶-9活性。
Transl Stroke Res. 2015 Apr;6(2):133-9. doi: 10.1007/s12975-014-0377-3. Epub 2014 Nov 27.
9
Recombinant factor VIIa use in patients presenting with intracranial hemorrhage.重组凝血因子VIIa在颅内出血患者中的应用。
Springerplus. 2014 Aug 27;3:471. doi: 10.1186/2193-1801-3-471. eCollection 2014.
10
Progressing haemorrhagic stroke: categories, causes, mechanisms and managements.进展性出血性卒中:分类、病因、机制及管理
J Neurol. 2014 Nov;261(11):2061-78. doi: 10.1007/s00415-014-7291-1. Epub 2014 Mar 5.

本文引用的文献

1
Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage.抗凝血相关脑出血患者应用凝血酶原复合物浓缩物对血肿扩大和临床转归的影响。
Cerebrovasc Dis. 2011;31(2):170-6. doi: 10.1159/000321766. Epub 2010 Dec 3.
2
Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage.实验性华法林相关性脑出血中止血治疗的疗效比较。
Stroke. 2011 Jan;42(1):191-5. doi: 10.1161/STROKEAHA.110.593541. Epub 2010 Dec 2.
3
First 20 years with recombinant FVIIa (NovoSeven).重组 FVIIa(诺维乐)使用的头 20 年。
Haemophilia. 2011 Jan;17(1):e172-82. doi: 10.1111/j.1365-2516.2010.02352.x.
4
Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system.重组活化因子 VII 在华法林相关的中枢神经系统出血患者中的安全性。
Stroke. 2010 Jul;41(7):1459-63. doi: 10.1161/STROKEAHA.110.581538. Epub 2010 Jun 3.
5
Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage.在华法林相关脑出血小鼠模型中,快速逆转抗凝可减少出血量。
J Cereb Blood Flow Metab. 2009 May;29(5):1015-21. doi: 10.1038/jcbfm.2009.27. Epub 2009 Mar 25.
6
Experimental model of warfarin-associated intracerebral hemorrhage.华法林相关脑出血的实验模型
Stroke. 2008 Dec;39(12):3397-404. doi: 10.1161/STROKEAHA.108.517482. Epub 2008 Sep 4.
7
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.凝血酶原复合物浓缩剂和重组活化凝血因子 VII 对维生素 K 拮抗剂诱导的抗凝作用。
Thromb Res. 2008;122(1):117-23. doi: 10.1016/j.thromres.2007.09.002. Epub 2007 Oct 31.
8
Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.凝血酶原复合物浓缩剂在逆转华法林抗凝作用中的作用:文献综述
Am J Hematol. 2008 Feb;83(2):137-43. doi: 10.1002/ajh.21046.
9
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.华法林相关性脑出血的治疗:文献综述与专家意见
Mayo Clin Proc. 2007 Jan;82(1):82-92. doi: 10.4065/82.1.82.
10
Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions.与口服抗凝治疗相关的脑出血:当前实践与未解决的问题。
Stroke. 2006 Jan;37(1):256-62. doi: 10.1161/01.STR.0000196989.09900.f8. Epub 2005 Dec 8.